Robert Joseph Moccia - Mar 30, 2022 Form 4 Insider Report for STRATA Skin Sciences, Inc. (SSKN)

Role: Chief Executive Officer, Director
Signature: /s/ Robert Joseph Moccia
Stock symbol: SSKN
Transactions as of: Mar 30, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/1/2022, 06:00 PM
Previous filing: Mar 24, 2022
Next filing: Apr 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SSKN	Employee Stock Option	Award	$0	+100K	+6.13%	$0.00	1.73M	Mar 30, 2022	Common Stock	100K	$1.45	Direct	F1
transaction	SSKN	Employee Stock Option	Award	$0	+60K	+3.46%	$0.00	1.79M	Mar 30, 2022	Common Stock	60K	$1.45	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1. Vesting of these options depends upon the Company's achievement of a specified net revenue in relation to the Company's budget over a 12-month period from January 1, 2022 through December 31, 2022. Each option represents a contingent right to receive one share of the Company's common stock at Target performance. The "Target" number of shares is reported. Possible payout ranges from 0% of Target if the Threshold goal is not met, 95% of Target if the Threshold is met but the Target goal is not met, 100% of Target if the Target goal is met but the Stretch goal is not met, and 105% of Target if the Stretch goal is met or exceeded. The options are otherwise subject to acceleration and cancellation in certain specified circumstances.
F2	2. Vesting of these options depends upon the Company's achievement of a specified five trading day volume weighted average per share price ending on December 31, 2022 in relation to the Company's budget target for December 31, 2022, subject to acceleration and cancellation in certain specified circumstances.

Content

1. Vesting of these options depends upon the Company's achievement of a specified net revenue in relation to the Company's budget over a 12-month period from January 1, 2022 through December 31, 2022. Each option represents a contingent right to receive one share of the Company's common stock at Target performance. The "Target" number of shares is reported. Possible payout ranges from 0% of Target if the Threshold goal is not met, 95% of Target if the Threshold is met but the Target goal is not met, 100% of Target if the Target goal is met but the Stretch goal is not met, and 105% of Target if the Stretch goal is met or exceeded. The options are otherwise subject to acceleration and cancellation in certain specified circumstances.

2. Vesting of these options depends upon the Company's achievement of a specified five trading day volume weighted average per share price ending on December 31, 2022 in relation to the Company's budget target for December 31, 2022, subject to acceleration and cancellation in certain specified circumstances.